Skip to main content
. 2019 Feb 19;51(4):601–608. doi: 10.1007/s11255-019-02098-1

Table 2.

Summary of 24-h urine oxalate excretion (mg/24 h), percent change overall and by type of hyperoxaluria

Groups Baseline period mean (SD) Treatment period mean (SD) Change from baseline mean (SD), (%) Follow-up mean (SD)
All subjects (n = 16) 77.7 (55.9) 63.7 (40.1)* − 13.9 (18.4), − 13.3 77.5 (49.2)
EH subjects (n = 5) 110.5 (82.9) 88.5 (57.1) − 22.0 (26.6), − 10.4 109.8 (71.9)
IH subjects (n = 11) 62.7 (33.8) 52.5 (25.6) − 10.2 (13.3), − 14.6 62.7 (28.2)

Data are shown mean (SD)

EH enteric hyperoxaluria, IH idiopathic hyperoxaluria

*p<0.05 for difference between baseline and treatment period